Cargando…

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator

The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) was rapidly identified as the critical functional receptor for SARS-CoV-2. ACE2 is well-known as a counter-regulator of the renin-angiote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Jingwei, Li, Zijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553008/ https://www.ncbi.nlm.nih.gov/pubmed/33072500 http://dx.doi.org/10.1016/j.apsb.2020.10.006

Ejemplares similares

SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
por: Qiu, Ye, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2
por: Sharma, Divakar, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020)

A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
por: Oz, Murat, et al.
Publicado: (2021)

Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2021)

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
por: Bourgonje, Arno R, et al.
Publicado: (2020)

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
por: Beyerstedt, Stephany, et al.
Publicado: (2021)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2
por: Clayton, Daniel, et al.
Publicado: (2015)

Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
por: Bian, Jingwei, et al.
Publicado: (2020)

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
por: Barker, Harlan, et al.
Publicado: (2020)

Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study
por: Shahbazi, Behzad, et al.
Publicado: (2022)

Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
por: Borkotoky, Subhomoi, et al.
Publicado: (2022)

Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor
por: Giordano, Deborah, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population
por: Sidhwani, Santosh Kumar, et al.
Publicado: (2023)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
por: Aleksova, Aneta, et al.
Publicado: (2021)

Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications
por: Kianmehr, Anvarsadat, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
por: Tikellis, Chris, et al.
Publicado: (2012)

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020)

Characterization of Angiotensin Converting Enzyme-2 (ACE2) in Human Urine
por: Lew, Rebecca A., et al.
Publicado: (2006)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Okoloko, Oghenemega, et al.
Publicado: (2021)

Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2
por: Zhao, Xuesen, et al.
Publicado: (2020)

Overexpression of the SARS-CoV-2 receptor angiotensin converting enzyme 2 in cardiomyocytes of failing hearts
por: Vukusic, Kristina, et al.
Publicado: (2022)

Angiotensin‐Converting Enzyme 2 (SARS‐CoV‐2 receptor) expression in human skeletal muscle
por: Perez‐Valera, Mario, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry
por: Hou, Yuxuan, et al.
Publicado: (2010)

Antibodies to the N-Terminal Domain of Angiotensin-Converting Enzyme (ACE2) That Block Its Interaction with SARS-CoV-2 S Protein
por: Krut, V. G., et al.
Publicado: (2021)

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
por: Curreli, Francesca, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
por: Alabsi, Sarah, et al.
Publicado: (2023)

Exposure to Particulate Matter Increases Expression of the Angiotensin converting enzyme-2 (ACE2) Receptor
por: Miyashita, Lisa, et al.
Publicado: (2022)

Investigation of Serum Angiotensin-Converting Enzyme (ACE) Concentration and ACE Gene Polymorphism in Patients With SARS-CoV-2 Pneumonia Admitted to the Emergency Department
por: Goren, Tarik, et al.
Publicado: (2022)

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature
por: Fignani, Daniela, et al.
Publicado: (2020)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Simko, Fedor, et al.
Publicado: (2022)

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020)

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
por: Xiang, Yusen, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brain
por: Ding, Qiyue, et al.
Publicado: (2020)

Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2)
por: Xiao, Fengxia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_up36maasvuo1fne82dc14vf5b4